News tagged with pharmaceutical

Vandetanib in thyroid cancer: Added benefit not proven

Vandetanib (trade name: Caprelsa) has been approved in Germany since February 2012 for the treatment of adult patients who have a particular form of aggressive thyroid cancer. In a new benefit assessment, the German Institute ...

Aug 02, 2013
popularity not rated yet | comments 0

Dexamethasone beats placebo for cancer-related fatigue

(HealthDay)—For patients with advanced cancer, dexamethasone is better than placebo for reducing cancer-related fatigue (CRF), according to a study published online July 29 in the Journal of Clinical On ...

Aug 01, 2013
popularity not rated yet | comments 0

Bayer Q2 profits jump on new drugs, lower charges (Update)

German drug and chemicals company Bayer AG says net profit rose 75 percent in the second quarter thanks to lower one-time charges and strong sales of new products including anti-clotting drug Xarelto and cancer drug Stivarga.

Jul 31, 2013
popularity not rated yet | comments 0

Photoprotection-deficient patients with CLE identified

(HealthDay)—Several subgroups of patients with cutaneous lupus erythematosus (CLE) are deficient in their use of photoprotection, according to a study published in the June issue of the Journal of the Am ...

Jul 18, 2013
popularity not rated yet | comments 0

Development of new diabetes drug halted by maker

(HealthDay)—The development of what might have become a significant diabetes drug has been halted by its maker amid concerns that the medication raises the risk for fractures, kidney problems and heart ...

Jul 10, 2013
popularity not rated yet | comments 0

New marker substance for cancer cells

Scientists from ETH Zurich have developed a new substance that enables certain tumour types to be rendered visible in high resolution using positron emission tomography. The so-called tracer has successfully ...

Jul 04, 2013
popularity 5 / 5 (1) | comments 0 | with audio podcast